OPNT - Opiant Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 566.6M
Enterprise Value 342.68M
Trailing P/E N/A
Forward P/E 1-19.39
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.12
Price/Book (mrq)3.31
Enterprise Value/Revenue 32.00
Enterprise Value/EBITDA 6-3.89

Trading Information

Stock Price History

Beta (3Y Monthly) 0.28
52-Week Change 3-24.95%
S&P500 52-Week Change 32.99%
52 Week High 322.45
52 Week Low 39.98
50-Day Moving Average 314.29
200-Day Moving Average 313.08

Share Statistics

Avg Vol (3 month) 320.95k
Avg Vol (10 day) 330.84k
Shares Outstanding 54.04M
Float 2.99M
% Held by Insiders 118.16%
% Held by Institutions 120.17%
Shares Short (Aug 15, 2019) 441.57k
Short Ratio (Aug 15, 2019) 41.66
Short % of Float (Aug 15, 2019) 41.12%
Short % of Shares Outstanding (Aug 15, 2019) 41.03%
Shares Short (prior month Jul 15, 2019) 459.14k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/1
Last Split Date 3Dec 31, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -49.74%
Operating Margin (ttm)-51.45%

Management Effectiveness

Return on Assets (ttm)-31.46%
Return on Equity (ttm)-74.64%

Income Statement

Revenue (ttm)21.34M
Revenue Per Share (ttm)5.84
Quarterly Revenue Growth (yoy)115.10%
Gross Profit (ttm)-9.71M
EBITDA -10.97M
Net Income Avi to Common (ttm)-10.61M
Diluted EPS (ttm)-2.90
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.92M
Total Cash Per Share (mrq)5.92
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.28
Book Value Per Share (mrq)4.98

Cash Flow Statement

Operating Cash Flow (ttm)-3.27M
Levered Free Cash Flow (ttm)817.71k